Home > Healthcare > Medical Devices > Medical Supplies > Biohazard Bags Market
Biohazard Bags Market size exceeded USD 389 million in 2022 and is set to depict over 7% CAGR through 2023-2032, considering the increasing population and urgent health care center expansion.
With healthcare growing more sophisticated due to the rising population, waste management has become a major challenge. The rate of medical waste generation has surged significantly, mainly due to the burgeoning number of research labs, clinics, hospitals, and diagnostic centers across the globe. In the U.S., hospitals generate close to 5.9 million tons of medical waste per year. This will lead to an increased focus on ensuring the safe disposal of medical waste including contaminated cotton and minimizing infection risks, thereby augmenting demand for biohazard waste bags.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Biohazard Bags Market Size in 2022: | USD 389 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 7% |
2032 Value Projection: | USD 773 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 183 |
Tables, Charts & Figures: | 275 |
Segments covered: | Capacity, Material, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The high prevalence of healthcare-acquired infections is another major factor creating lucrative growth prospects for biohazard bag developers. This growing disease burden will help improve medical fluid bag production and consequently bolster the usage of biohazard disposable bags. Despite the growth trajectory, the lack of awareness regarding the improper disposal of syringes and other hazardous waste may hinder industry development to some extent, especially in low-income countries.
Based on the capacity, the biohazard bags market value from the more than 35-gallon segment reached USD 200 million in 2022. Hazardous waste bags with a capacity of 35-gallons and over have a 1.2-millimeter liner low density, providing excellent puncture and tear resistance. Due to their thickness, these waste bags can reduce contamination risks during the disposal, treatment, and collection of medical waste, thereby increasing product acceptance in nursing centers, labs, and hospitals. Furthermore, the capability to carry heavy medical waste will stimulate the usage of these biohazard bags across healthcare facilities.
The polypropylene material segment accounted for more than 32.5% share of the biohazard bags market in 2022, owing to the product’s effectiveness in tubes, micro tips, and other light instrument disposals. Sample storage bags made of liner low-density PP can also withstand high-temperature sterilization and are easy to open, making them suitable for lightweight hazardous waste collection. In addition, the growing regulatory focus on the use of essential healthcare equipment such as autoclave machines for efficient waste treatment will also boost the requirement for PP autoclavable biohazard bags.
In terms of the end-use, the biohazard bags market share from the clinics and diagnostic centers segment is poised to depict an 8% CAGR through 2023-2032, on account of the rising emphasis on enhancing patient care through the expansion of healthcare facility networks. To cite an instance, in April 2022, Mayo Clinic announced USD 49 million in investment in a laboratory expansion project in Rochester. The rise in need for proper medical waste disposal at these facilities will therefore amplify the demand for biohazard bags.
The growing burden of chronic diseases will also accelerate medical waste generation and in turn, proliferate biohazard bag consumption across clinics and diagnostic centers. For instance, the recent COVID-19 outbreak led to a significant increase in the generation of medical waste in clinics and diagnostic facilities, further driving product consumption.
North America held over 40% share of the global biohazard bags market in 2022. The issuance of strict guidelines from government agencies including the U.S. CDC to ensure proper collection and disposal of healthcare waste is one of the key drivers impelling industry progress. As per the guidelines issued during the coronavirus outbreak, for instance, sharp medical waste was to be disposed of in red biohazard bags. Moreover, the introduction of regulatory policies to mitigate the impact of infectious diseases due to improper waste disposal will also drive product consumption across the region.
are some of the key players in the biohazard bags market. These companies are incorporating strategies such as acquisitions, new product launches, and collaborations to expand their customer base in the global industry.
For instance, in February 2022, Sharps Compliance Corp. acquired Midwest Medical Waste, Inc., a hazardous and medical waste solution provider to above 600 customers in Kansas. This initiative was intended to enable the company to reinforce its presence in the market.
An upsurge in the volume of medical waste is among the prominent trends being observed following the COVID-19 outbreak. In China, for example, more than 247 tons of medical waste was generated in Wuhan alone during the peak of the pandemic, 6 times higher than the pre-pandemic levels. Since this waste is considered highly hazardous and therefore requires proper disposal methods, the demand for biohazard bags is rising steadily. The mounting generation of healthcare waste such as contaminated syringes and the issuance of strict mandates to separate COVID-19 waste is also likely to boost product adoption over the forthcoming years, bolstering the market outlook.
Click here to Buy Section of this Report
By Capacity
By Material
By End-use
The above information is provided for the following regions and countries: